CE 1037
Alternative Names: MDL 201404; UT 77Latest Information Update: 30 Jun 2000
At a glance
- Originator Cortech; The Research Foundation of State University of New York
- Class
- Mechanism of Action Leucocyte elastase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Adult respiratory distress syndrome; Chronic obstructive pulmonary disease; Cystic fibrosis; Emphysema
Most Recent Events
- 30 Jun 2000 Discontinued-II for Adult respiratory distress syndrome in USA (Unknown route)
- 30 Jun 2000 Discontinued-II for Chronic obstructive pulmonary disease in USA (Unknown route)
- 30 Jun 2000 Discontinued-II for Cystic fibrosis in USA (Unknown route)